2024-11-13


Shanghai Huanghai Pharmaceutical, a subsidiary of Shanghai Baiyang Pharmaceutical, won the 2024 Excellent Quality Award for Pharmaceutical Enterprises

On September 19th, at the 2nd Pharmaceutical High Quality Development Industry Conference and China Pharmaceutical Managers Annual Meeting in 2024, the list of excellent quality awards for pharmaceutical enterprises in 2024 was officially announced. Shanghai Huanghai Pharmaceutical Co., Ltd. won the "2024 Pharmaceutical Enterprise Excellent Quality Award" for its excellent quality management system and excellent product quality.

This selection is based on multiple dimensions such as regional development, enterprise regulatory data, product market feedback, quality management maturity, and regional role model strength. After a series of objective, fair, and impartial selection procedures including material review, joint recommendation, and deliberation voting, 20 enterprises were ultimately selected.

Quality is the life of drugs. Winning this heavyweight award is not only another milestone in drug quality control, but also a powerful proof of the company's comprehensive strength and industry influence, demonstrating its outstanding contribution to promoting the high-quality development of the traditional Chinese medicine industry.

The company has a complete management system covering the entire lifecycle of drugs, implementing full staff, comprehensive, and whole process quality control to more effectively control and trace product quality, and achieve refined quality management throughout the entire lifecycle.

Quality improvement is endless, and advanced production equipment and technological processes are the guarantee of high-quality products and the core competitiveness. At present, the company has established a digital traditional Chinese medicine extraction workshop and analysis and testing center for the international market. In the future, the company will continue to upgrade from "manufacturing" to "intelligent manufacturing", continuously improve the level of product technology and competitive advantages, promote the construction of "digitalized" factories, and establish a model and benchmark for intelligent manufacturing.

                               The third person on the left is Ms. Wei Na, Quality Director of Shanghai Huanghai Pharmaceutical Co., Ltd.,

Related News